Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today on the Internet.
Press releases published on May 6, 2025
Sagtec Global Secures US$30 Million Revenue Pipeline Through Exclusive UAE Partnership, Accelerating Global Expansion
GlobeNewswire
·
May 6, 2025
KUALA LUMPUR, Malaysia, May 06, 2025 (GLOBE NEWSWIRE) -- Sagtec Global Limited (NASDAQ: SAGT) (“Sagtec” or the “Company”), a leading provider of customizable software solutions, today announced its international growth strategy through the signing of a …
Alico to Participate at the BMO Global Farm to Market Conference
GlobeNewswire
·
May 6, 2025
FORT MYERS, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that John Kiernan, the Company’s President and Chief Executive Officer, will host one-on-one meetings with investors at the BMO Global …
3D Systems’ NextDent® Material Portfolio Addressing Broadest Set of Patient-specific Indications
GlobeNewswire
·
May 6, 2025
3D Systems’ NextDent branded dental materials have set the benchmark for quality and aesthetics, addressing the broadest set of patient-specific dental solutions in the world NextDent materials form the foundation for 3D Systems’ dental ‘repair’ offerings …
SIOS Technology to Demonstrate High Availability Clustering Software for Mission-Critical Applications at Red Hat Summit, Milestone Technology Day and XPerience Day, and SQLBits 2025
GlobeNewswire
·
May 6, 2025
SAN MATEO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- SIOS Technology Corp., a leading provider of application high availability (HA) and disaster recovery (DR) solutions, today announced it will demonstrate its high availability clustering software for …
Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025
GlobeNewswire
·
May 6, 2025
SEATTLE and VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV) a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …
Alpha Tau to Participate in May Investor Conferences
GlobeNewswire
·
May 6, 2025
JERUSALEM, May 06, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will presentation in …
Palisade Bio Presents Positive Preclinical Data Highlighting Potential of PALI-2108 as a Promising Colon-Specific PDE4 Inhibitor for the Treatment of Ulcerative Colitis and Other Inflammatory Bowel Diseases
GlobeNewswire
·
May 6, 2025
Two posters presented at Digestive Disease Week (DDW) 2025 Preclinical results indicate that PALI-2108 effectively modulates inflammatory pathways in the colon, promoting a favorable immune response Company advancing Phase 1a/b study of PALI-2108 and has …
PodcastOne (NASDAQ: PODC) and Kaitlyn Bristowe Celebrate 10 Year Anniversary of Her Season of ABC’s The Bachelorette with Special Edition of Off the Vine with Kaitlyn Bristowe Podcast
GlobeNewswire
·
May 6, 2025
LOS ANGELES, May 06, 2025 (GLOBE NEWSWIRE) -- PodcastOne (NASDAQ: PODC), a leading publisher and podcast sales network, announced today that podcast host Kaitlyn Bristowe is celebrating her pinnacle season of ABC’s long running Bachelorette franchise with …
New Book Captures the Entrepreneurial Spirit and Values-Driven Leadership of Hospitality Industry Icon Bruce White
GlobeNewswire
·
May 6, 2025
Merrillville, Indiana, May 06, 2025 (GLOBE NEWSWIRE) -- Forty years ago, Bruce White founded White Lodging in 1985 in Northwest Indiana with a single hotel and built the company into one of the largest and most respected hospitality companies in the United …
Allogene Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update
GlobeNewswire
·
May 6, 2025
Conference Call and Webcast Scheduled for May 13, 2025 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development …
Maybacks Global Entertainment and Whale TV Launch iDreamCTV App Across Global Smart TV Platforms
GlobeNewswire
·
May 6, 2025
LOS ANGELES, May 06, 2025 (GLOBE NEWSWIRE) -- via IBN -- Maybacks Global Entertainment, a subsidiary of Authentic Holdings, Inc. (OTC PINK: AHRO), in partnership with Whale TV (https://www.whaletv.com), is proud to announce the launch of the iDreamCTV App …
Orion Highlights Demand for its Energy Efficient Lighting Fixtures and Buy American Act Compliant LED Lighting at LightFair 2025 May 6-8 (Booth 1811)
GlobeNewswire
·
May 6, 2025
LAS VEGAS and MANITOWOC, Wis., May 06, 2025 (GLOBE NEWSWIRE) -- Orion Energy Systems, Inc.(NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle charging station and maintenance services solutions, today disclosed …
Plotly Showcases AI-powered Platform for Interactive Data Application Development at Leading Industry Events in May and June 2025
GlobeNewswire
·
May 6, 2025
MONTREAL, May 06, 2025 (GLOBE NEWSWIRE) -- Plotly, the premier Data App platform for Python, today announced it will participate in multiple leading industry events in May and June, 2025, where Plotly experts and users will share their unique insights and …
FOXO TECHNOLOGIES INC.’S BEHAVIORAL HEALTH SUBSIDIARY REACHES KEY OPERATIONAL MILESTONES
GlobeNewswire
·
May 6, 2025
WEST PALM BEACH, FLORIDA, May 06, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its behavioral health subsidiary, Myrtle Recovery Centers, Inc., has reached key patient care milestones. …
IMUNON Announces Data from Phase 1/2 Trial Evaluating Intraperitoneal IMNN-001 in Combination with Neoadjuvant Chemotherapy in Newly Diagnosed Patients with Advanced Epithelial Ovarian Cancer to be Published in Gynecologic Oncology
GlobeNewswire
·
May 6, 2025
Data from OVATION 2 trial will also be reviewed in an oral presentation at ASCO Annual Meeting on June 3, 2025 LAWRENCEVILLE, N.J., May 06, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its …
Candel Therapeutics to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 6, 2025
NEEDHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, …
Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference
GlobeNewswire
·
May 6, 2025
WALTHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
New Survey Shows College Students Overestimate Their Career Readiness
GlobeNewswire
·
May 6, 2025
Washington, DC, May 06, 2025 (GLOBE NEWSWIRE) -- A new national survey of more than 2,000 college juniors and seniors by Seramount, a global talent solution company, highlights a growing disconnect between student and employer perceptions of career …
Majority of Advertisers Report DSP Access Would Unlock More Budget for Retail Media, According to New Koddi Survey
GlobeNewswire
·
May 6, 2025
FORT WORTH, Texas, May 06, 2025 (GLOBE NEWSWIRE) -- Koddi, the leading retail and commerce media technology for enterprises, revealed that the majority of both brands and agencies say that DSP access would encourage them to move more of their non-retail …
Boehringer Ingelheim starts Phase II study of its potential first-in-class oral compound as a treatment for Geographic Atropy
GlobeNewswire
·
May 6, 2025
Ingelheim, Germany, May 6, 2025 – Boehringer Ingelheim today announces the start of the JADE Phase II clinical study (NCT06769048), investigating the efficacy and safety of BI 1584862 as a potential first-in-class treatment for geographic atrophy (GA).[1 …